| Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo KJ Lavender, K Gibbert, KE Peterson, E Van Dis, S Francois, T Woods, ... Journal of virology 90 (13), 6001-6013, 2016 | 123 | 2016 |
| BLT-humanized C57BL/6 Rag2−/−γc−/−CD47−/− mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection KJ Lavender, WW Pang, RJ Messer, AK Duley, B Race, K Phillips, D Scott, ... Blood, The Journal of the American Society of Hematology 122 (25), 4013-4020, 2013 | 119 | 2013 |
| Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection HB Kramer, KJ Lavender, L Qin, AR Stacey, MKP Liu, K di Gleria, ... PLoS pathogens 6 (5), e1000893, 2010 | 106 | 2010 |
| Loss of DNAM‐1 contributes to CD8+ T‐cell exhaustion in chronic HIV‐1 infection M Cella, R Presti, W Vermi, K Lavender, E Turnbull, ... European journal of immunology 40 (4), 949-954, 2010 | 57 | 2010 |
| An advanced BLT-humanized mouse model for extended HIV-1 cure studies KJ Lavender, C Pace, K Sutter, RJ Messer, DL Pouncey, NW Cummins, ... Aids 32 (1), 1-10, 2018 | 53 | 2018 |
| Ly-49 receptors and their functions KP Kane, KJ Lavender, BJ Ma Critical Reviews™ in Immunology 24 (5), 2004 | 35 | 2004 |
| Allelic variation in the ectodomain of the inhibitory Ly-49G2 receptor alters its specificity for allogeneic and xenogeneic ligands ET Silver, KJ Lavender, DE Gong, B Hazes, KP Kane The Journal of Immunology 169 (9), 4752-4760, 2002 | 35 | 2002 |
| Production of bone marrow, liver, thymus (BLT) humanized mice on the C57BL/6 Rag2−/− γc−/− CD47−/− background KJ Lavender, RJ Messer, B Race, KJ Hasenkrug Journal of immunological methods 407, 127-134, 2014 | 33 | 2014 |
| Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection J Schuhenn, TL Meister, D Todt, T Bracht, K Schork, JN Billaud, C Elsner, ... Proceedings of the National Academy of Sciences 119 (8), e2111600119, 2022 | 31 | 2022 |
| Severity of disease in humanized mice infected with Ebola virus or Reston virus is associated with magnitude of early viral replication in liver JR Spengler, G Saturday, KJ Lavender, C Martellaro, JG Keck, ST Nichol, ... The Journal of infectious diseases 217 (1), 58-63, 2018 | 27 | 2018 |
| Ebola virus replication and disease without immunopathology in mice expressing transgenes to support human myeloid and lymphoid cell engraftment JR Spengler, KJ Lavender, C Martellaro, A Carmody, A Kurth, JG Keck, ... The Journal of infectious diseases 214 (suppl_3), S308-S318, 2016 | 24 | 2016 |
| Qualitative differences between the IFNα subtypes and IFNβ influence chronic mucosal HIV-1 pathogenesis K Guo, G Shen, J Kibbie, T Gonzalez, SM Dillon, HA Smith, EH Cooper, ... PLoS pathogens 16 (10), e1008986, 2020 | 22 | 2020 |
| Mice of the resistant H-2b haplotype mount broad CD4+ T cell responses against 9 distinct Friend virus epitopes RJ Messer, KJ Lavender, KJ Hasenkrug Virology 456, 139-144, 2014 | 22 | 2014 |
| Pathogenicity of ebola and marburg viruses is associated with differential activation of the myeloid compartment in humanized triple knockout-bone marrow, liver, and thymus mice KJ Lavender, BN Williamson, G Saturday, C Martellaro, A Griffin, ... The Journal of Infectious Diseases 218 (suppl_5), S409-S417, 2018 | 20 | 2018 |
| Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir K Sutter, KJ Lavender, RJ Messer, M Widera, K Williams, B Race, ... Scientific reports 9 (1), 18089, 2019 | 17 | 2019 |
| No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts ES Van Dis, TC Moore, KJ Lavender, RJ Messer, OT Keppler, J Verheyen, ... Virology 488, 88-95, 2016 | 16 | 2016 |
| Cross-species dependence of Ly49 recognition on the supertype defining B-pocket of a class I MHC molecule KJ Lavender, KP Kane The Journal of Immunology 177 (12), 8578-8586, 2006 | 11 | 2006 |
| The rat RT1-A1c MHC molecule is a xenogeneic ligand recognized by the mouse activating Ly-49W and inhibitory Ly-49G receptors KJ Lavender, BJ Ma, ET Silver, KP Kane The Journal of Immunology 172 (6), 3518-3526, 2004 | 11 | 2004 |
| CHAVI Clinical Core B M Cella, R Presti, W Vermi, K Lavender, E Turnbull, ... NIAID Center for HIV/AIDS Vaccine Immunology, 949-954, 2010 | 9 | 2010 |
| Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice SS Rout, Y Di, U Dittmer, K Sutter, KJ Lavender Aids 36 (3), 325-336, 2022 | 7 | 2022 |
